<DOC>
	<DOCNO>NCT01491516</DOCNO>
	<brief_summary>The purpose pilot study evaluate feasibility implant ( TELAMON P™ Implant/INFUSE Bone Graft System use conjunction CD HORIZON® Spinal System ) method facilitate lumbar spinal fusion utilize posterior surgical approach patient symptomatic degenerative disc disease . The safety effectiveness implant evaluate .</brief_summary>
	<brief_title>TELAMON P™ Implant/INFUSE® Bone Graft/CD HORIZON® Spinal System Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>1 . Has degenerative disc disease note back pain discogenic origin , without leg pain , degeneration disc confirm patient history radiographic study include one following : instability ( define angulation &gt; = 5° and/or translation &gt; = 4mm , base flexion/extension radiograph ) ; osteophyte formation ; decrease disc height ; thicken ligamentous tissue ; disc degeneration herniation ; and/or facet joint degeneration . 2 . Has preoperative Oswestry score &gt; = 30 . 3 . Has preoperative back pain score &gt; = 25 base Preoperative Back Leg Pain Questionnaire ( intensity duration ) . 4 . Has great Grade 1 spondylolisthesis utilize Meyerding 's Classification ( Meyerding , HW , 1932 ) . 5 . Requires fusion single level disc space L 1 S 1 . 6 . Is least 18 year age , inclusive , time surgery . 7 . Has respond nonoperative treatment period 6 month . 8 . If childbearing potential , patient nonpregnant , nonnursing , agree get pregnant 1 year follow surgery . 9 . Is willing able comply study plan sign Patient Informed Consent Form . 1 . Has primary diagnosis spinal disorder degenerative disc disease Grade 1 less spondylolisthesis involve level . 2 . Had previous spinal fusion surgical procedure involve level . 3 . Requires spinal fusion one lumbar level . 4 . Has condition require postoperative medication interfere fusion , steroid prolong use nonsteroidal antiinflammatory drug exclude routine perioperative nonsteroidal antiinflammatory drug . This include low dose aspirin prophylactic anticoagulation . 5 . Has previously diagnose osteopenia osteomalacia . 6 . Has follow may associate diagnosis osteoporosis ( `` Yes '' risk factor , dual xray absorptiometry ( DEXA ) Scan require determine eligibility ) . 1 . Postmenopausal NonBlack female 60 year age weigh less 140 pound . 2 . Postmenopausal female sustain nontraumatic hip , spine , wrist fracture . 3 . Male age 70 . 4 . Male age 60 sustain nontraumatic hip spine fracture . If level BMD T score 3.5 T score 2.5 vertebral crush fracture , patient exclude study . 7 . Has presence active malignancy prior history malignancy , except basal cell carcinoma skin . 8 . Has overt active bacterial infection , either local systemic . 9 . Has document titanium , titanium alloy , tantalum , tantalum alloy , polyetheretherketone allergy intolerance . 10 . Is mentally incompetent . If questionable , obtain psychiatric consult . 11 . Has Waddell Signs Inorganic Behavior score 3 great . 12 . Is prisoner . 13 . Is alcohol and/or drug abuser define currently undergo treatment alcohol and/or drug abuse . 14 . Has receive drug may interfere bone metabolism within two week prior plan date spinal fusion surgery ( e.g. , steroids methotrexate ) , exclude routine perioperative antiinflammatory drug . 15 . Has history autoimmune disease ( e.g . Systemic Lupus Erythematosus Dermatomyositis ) . 16 . Has history exposure injectable collagen silicone implant . 17 . Has history hypersensitivity protein pharmaceutical ( e.g . monoclonal antibody gamma globulin ) collagen . 18 . Has receive treatment investigational therapy ( device and/or pharmaceutical ) within 28 day prior implantation surgery treatment plan 16 week follow investigational treatment . 19 . Has receive previous exposure any/all BMP 's either human animal extraction . 20 . Has history allergy bovine product history anaphylaxis . 21 . Has history endocrine metabolic disorder know affect osteogenesis ( e.g. , Paget 's disease , renal osteodystrophy , EhlersDanlos syndrome , osteogenesis imperfecta ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Lumbar degenerative disc disease</keyword>
</DOC>